The prognosis of hexacarbon induced polyneuropathy is usually good, though its clinical course after the cessation of exposure has not been described in detail. Eleven patients with moderate to severe n-hexane induced polyneuropathy due to occupational exposure were regularly followed up for a period offour years at the neurological department of the National Taiwan University Hospital. Sensorimotor neuropathy was diagnosed in nine patients and motor neuropathy in two. All were removed from further exposure to n-hexane Thereafter, both the CNS and PNS manifestations were regularly followed up for four years in 11 of the 28 patients. Special attention was given to the "delayed worsening" of symptoms after cessation of exposure. In the present paper changes in the clinical manifestations on recovery are reported and analysed.
The prognosis of hexacarbon induced polyneuropathy is usually good, though its clinical course after the cessation of exposure has not been described in detail. Eleven patients with moderate to severe n-hexane induced polyneuropathy due to occupational exposure were regularly followed up for a period offour years at the neurological department of the National Taiwan University Hospital. Sensorimotor neuropathy was diagnosed in nine patients and motor neuropathy in two. All were removed from further exposure to n-hexane after aetiological confirmation, but motor disturbance continued to worsen in five cases. Sensory functions were regained earlier than motor functions. All the patients, including one who was tetraplegic and confined to a wheelchair in the early stages, regained their full motor capabilities within one to four years. Three patients with severe neuropathy had residual muscle atrophy in the intrinsic foot and hand muscles. Signs of damage to the central nervous system, including increased tendon reflexes in two patients and leg tightness in six patients, emerged as muscle power was nearing complete recovery. The tightness of the legs gradually disappeared, but muscle cramps of the calves developed and these were still present at the end of follow up. Two patients had mild abnormal colour vision, and the abnormality was still detectable four years later. It is concluded that n-hexane induced neuropathy has a good prognosis, and that spasticity due to damage to the central nervous system is functionally reversible; muscle cramps and dyschromatopsia persist much longer. Tightness of the legs was a complaint of six patients, mainly in those with 'severe neuropathy. They usually described tightness of the hamstrings in the morning, which lessened to some extent after walking or exercise. No obvious spastic gait was found during the follow up neurological examinations. Leg tightness commonly developed eight to 15 months after onset of neuropathy and gradually diminished six to 20 months later (fig 2) .
MUSCLE CRAMPS
Muscle cramps in the legs, especially in the calves, were reported by those patients with leg tightness. Cramps occurred almost exclusively in the early morning just after waking. When their motor activity improved to grade 1, tightness of the legs gradually lessened, but muscle cramps became more unpleasant. This symptom was still present at the last visit four years after onset of neuropathy (fig 2) . Muscle cramps in the most severely afflicted victim also occurred after exercise and involved both feet and hands. Table 3 lists the initial neurographic findings from the right limbs. A pronounced decrease in nerve conduction velocities (NCVs), profound amplitude reduction of muscle action potentials (MAPs) and sensory action potentials (SAPs), and obvious prolongation of distal latencies were characteristic.
ELECTRONEUROGRAPHIC FINDINGS
On serial neurographic follow up, a further decrease in the amplitude of MAPs in at least one nerve was found in six patients, mainly in the peroneal nerve. Five patients had further slowing of motor NCVs, but distal latencies improved. In sensory conduction studies a further reduction of SAP amplitude was seen in five patients. Delayed Table 3 Muscle cramp, which followed closely the disappearance or diminution of spasticity, was an unpleasant symptom. Cramp like muscular pain was one of the major subjective symptoms among shoe industry workers with n-hexane induced neuropathy.' In the Ohio outbreak of methyl n-butyl ketone intoxication Allen and colleagues also described mild cramping discomfort as one of the early sensory complaints of patients.3 Muscle cramps in the present group, which persisted until the end of the follow up, seemed different from those mentioned in previous reports. It is known that pathological muscle cramps can occur in motor unit hyperactivity, in some neuropathies, in a few muscle diseases, and with changes in composition of extracellular fluid. Considering the chronological sequence, the muscle cramps in these patients seemed not to be a sign of peripheral nerve involvement. Also, in view of the degeneration in the motor pathways in the lumbar spinal cord of hexacarbon intoxicated animals'2 and the increased excitability of alpha motorneurons in patients with n-hexane induced polyneuropathy,'5 it is postulated that muscle cramp is a sign of CNS damage in nhexane intoxication and results from denervational hyperactivity of alpha motorneurons in the spinal cord.
Abnormal colour vision, associated with mild pigment dystrophy and perifoveal capillary proliferation, has been reported among industrial workers exposed to n-hexane vapour at concentrations of 423-1280 ppm for more than five years; these ophthalmological signs were regarded as a toxic effect of n-hexane.'6 Two patients in the present study had mild dyschromatopsia at first examination (colour plate screening test) and the colour vision defect was still detectable four years later (100 hue test). Maculopathy in these patients was confirmed on funduscopic examination by an ophthalmologist. Impairment of colour vision seemed to be irreversible.
Delayed worsening of electrodiagnostic findings after exposure had ceased was first mentioned in the Ohio outbreak of methyl n-butyl ketone induced polyneuropathy.7 Cianchetti and colleagues also noted a delayed deterioration in motor nerve conduction velocity in toxic polyneuropathy among shoe industry workers.8 The delayed development of electrodiagnostic abnormalities was common in the present group. Detailed neurographic findings and studies of evoked potentials at follow up will be reported elsewhere.
This study indicates that patients with n-hexane induced neuropathy have a good prognosis, even those confined to a wheelchair in the early stages. Spasticity emerging on recovery is functionally reversible, but muscle cramps and abnormal colour vision are probably permanent. 
